TECHNOLOGY INTEGRATION AGREEMENT

 

This Technology Integration Agreement (this “Agreement”) is made effective as of
1 January 2019 (the “Effective Date”) by and between Alliance Pharma Solutions,
a Delaware limited liability company, having an office at 3840 Land O’ Lakes
Blvd., Land O’ Lakes, FL 34639, or its nominee, (“Alliance”), and SyncHealth
MSO, LLC, a Delaware limited liability company, having an office at 2107 Gunn
Hwy, Odessa, FL 33556 (“SyncHealth”). SyncHealth and Alliance are each referred
to herein as a “Party” or collectively as the “Parties.”

 

RECITALS:

 

WHEREAS, Alliance and SyncHealth member PanOptic Health, LLC. Delaware limited
liability company (“PanOptic”) have entered into that certain “Contribution
Agreement” dated of even date herewith, that certain “Operating Agreement of
SyncHealth LLC” dated of even date herewith and that certain “Letter Agreement”
of even date herewith (collectively with any exhibits, schedules, annex and
amendments thereto, the “Transaction Documents”) pursuant to which Alliance and
PanOptic have contributed assets to SyncHealth and Alliance and PanOptic have
agreed to enter into this Agreement to pursue the Business Purpose (defined
below);

 

WHEREAS, SyncHealth is in the business of providing prescription management
software known as E-Hub Services described on Schedule 1.22(g) to the
Contribution Agreement (the “SyncHealth Application”) to health care providers
and pharmacies;

 

WHEREAS, Alliance, itself and through its Affiliates, is engaged in the business
of (i) providing an online platform for independent licensed pharmacies to
purchase pharmaceuticals from licensed wholesale distributors (the “Alliance
Network”); (ii) wholesale pharmaceutical sales, logistics and logistic services
(“Integra Pharma Services”); and (iii) delivery of pharmaceuticals directly to
patients (the “DelivMeds Application”);

 

WHEREAS, Alliance and SyncHealth contemplate that they wish to participate in
the exchange of technology to ensure a more complete integration of the two
companies’ technologies for their respective end user customers and prospective
customers (“End Users”); and

 

WHEREAS, pursuant to the Transaction Documents, the integration of the
respective Party’s Products (defined below) will create an integrated healthcare
platform capable of driving value between prescription origination and final
patient delivery under one unified healthcare platform (collectively, the
“Business Purpose”). 

 

   

 

 

NOW, THEREFORE, in consideration of the mutual promises contained in this
Agreement and other good and valuable consideration, the parties, intending to
be legally bound, agree as follows:

 

1. Definitions.

 

  a. “Affiliate” means any entity which controls, is controlled by, or is under
common control with a Party, where “control” means the legal, beneficial or
equitable ownership of at least a majority of the aggregate of all voting equity
interests in such entity.         b. “Effective Date” means the effective date
stated on the signature page of this Agreement, or if no effective date is
stated, the date of last signature on this Agreement.         c. “Initial Term”
has the meaning given in Section 6(a) (Term and Termination).         d.
“Intellectual Property” means any right recognized as intellectual property in
any jurisdiction worldwide, or any information or materials eligible for
recognition as intellectual property with the passage of time, filing of an
application, or other event. Examples of Intellectual Property include, without
limitation, copyrights, trade secrets, patents, Marks, moral rights, the right
to make a governmental application to register or issue any of them, and the
right to prosecute an infringement action in respect of any of them.         e.
“Mark” means a trademark, services mark, trade name, trade dress, or similar
identifying indicia.         f. “Marketing Materials” means any information or
material used to market or promote a Party’s Products, whether in print,
digital, audio, video or any other form or media. Examples of Marketing
Materials are, without limitation: advertisements, web content, web banners, web
links, data, test results, white papers, survey results, trade show exhibits,
shirts, hats, cups, golf balls, pens, food wrappers, and printed matter.        
g. “Renewal Term” has the meaning given in Section 6(a) (Term and Termination).
        h. “SyncHealth Products” means certain software products, services and
projects developed and owned by SyncHealth, its Affiliates and their licensors,
as the same may be modified by SyncHealth, its Affiliates and their licensors
from time to time, including without limitation the SyncHealth Application.    
    i. “SyncHealth API” means (i) the application programming interface(s)
(“API”) and data feeds made available by SyncHealth under this Agreement, (ii)
documentation, materials, sample code and software (including any human-readable
programming instructions) relating to an API or data feed, (iii) data and
information, including SyncHealth’s proprietary directory of hyperlinks to the
SyncHealth Application provided to the Alliance Products through an API or data
feed (“SyncHealth API Data”); and (iv) the credentials assigned to Alliance or
the Alliance Products by SyncHealth.

 

   

 

 

  j. “Term” means the Initial Term and any Renewal Term, collectively.        
k. “Alliance API” means (i) the application programming interface(s) (“API”) and
data feeds made available by Alliance under this Agreement, (ii) documentation,
materials, sample code and software (including any human-readable programming
instructions) relating to an API or data feed, (iii) data and information,
including Alliance’s proprietary directory of hyperlinks to Alliance Products,
provided to the SyncHealth Application through an API or data feed (“Alliance
API Data”); and (iv) the credentials assigned to SyncHealth or the SyncHealth
Application by Alliance.         l. “Alliance Products” means certain software
products, services and projects developed and owned by Alliance, its Affiliates
and their licensors, as the same may be modified by Alliance, its Affiliates and
their licensors from time to time, including without limitation the Alliance
Platform, the Integra Pharma Services and the DelivMeds Application.

 

2. Grant.

 

  a. Alliance hereby grants SyncHealth a non-exclusive right to market, promote
and demonstrate the Alliance Products to End Users. SyncHealth hereby grants
Alliance the exclusive right to market, promote and demonstrate the SyncHealth
Products to End Users. Unless the appropriate documents and provisions are
mutually agreed upon by the parties, neither Party shall, however, make any
offer to or enter into any agreement with a potential End User with respect to
the other Party’s products, but will refer potential End Users to the other
Party. Each Party shall have access to and is entitled to provide a potential
End User with official Marketing Material regarding the other Party’s products.
        b. Each Party shall use reasonable efforts to keep the other Party
generally informed of its marketing and promotion activities relating to the
other Party’s products. The Parties may only use marketing and promotional
material provided by the other Party when performing marketing and promotion
activities relating to the other Party’s products. The Parties are aware of the
fact that:

 

  i. each Party is marketing and promoting their respective products and
services on a nation-wide basis in the United States; and         ii. Alliance
has engaged or may in the future engage other partners in any territory to
perform the same or similar services as set out in this Agreement. SyncHealth
agrees that it is not now and will not in the future engage other partners in
any territory to perform the same or similar services as set out in this
Agreement. Each Party shall exercise its rights under this Agreement in
accordance with the terms and conditions contained herein and shall conduct
itself with the skill and care of a reputable firm or independent contractor
within the Party’s field of business. Neither Party shall make representations
or warranties on behalf of the other Party, represent that it has any authority
to assume or create any obligation, expressed or implied, on behalf of the other
Party, or represent that the other Party is responsible, in contract or
otherwise, beyond those obligations specifically undertaken by the other Party
in this Agreement.

 

   

 

 

3. License.

 

  a. Alliance hereby grants SyncHealth a non-exclusive, non-transferable,
royalty free, revocable license during the Term of this Agreement to access the
Alliance Products to be made available to SyncHealth by Alliance, at Alliance’s
discretion, solely for the purpose of evaluating, testing, certifying,
marketing, promoting and demonstrating the Alliance Products solely in
conjunction with SyncHealth’s Products. SyncHealth hereby grants Alliance the
exclusive, transferable and sublicensable (to Affiliates, subcontractors and
channel partners), royalty free, irrevocable license during the Term of this
Agreement to access the SyncHealth Products to be made available to Alliance by
SyncHealth, in SyncHealth’s discretion, solely for the purpose of evaluating,
testing, certifying, marketing, promoting and demonstrating the SyncHealth
Products solely in conjunction with the Alliance Products. Neither Party will
use the other Party’s products to process any data in a production environment
or otherwise make commercial use or offer to make commercial use of the other
Party’s products.         b. Subject to the terms and conditions of this
Agreement, Alliance hereby grants to SyncHealth, and SyncHealth hereby accepts,
a non-exclusive, non-transferable, non-sublicensable and revocable right and
license during the Term to access and use the Alliance API solely to develop,
reproduce and distribute SyncHealth Applications and incorporate the Alliance
APIs into SyncHealth Applications for the purpose of delivering Alliance and
SyncHealth Products to End Users.         c. Subject to the terms and conditions
of this Agreement, SyncHealth hereby grants to Alliance, and Alliance hereby
accepts, an exclusive, transferable and sublicensable (as described below) and
irrevocable right and license during the Term to access and use the SyncHealth
API solely to develop, reproduce and distribute Alliance applications and
incorporate the Alliance APIs into Alliance Products for the purpose of
delivering Alliance and SyncHealth Products to End Users.

 

   

 

 

  d. SyncHealth shall retain ownership to the SyncHealth Products and derivative
works thereof and Alliance shall retain ownership of the Alliance Products and
derivative works thereof. Nothing in this Agreement shall confer any rights in
either Party’s intellectual property except as expressly provided for herein.
Neither Party shall:

 

  i. copy or manufacture the other Party’s products or any portion thereof;    
    ii. translate, modify, adapt, enhance, extend, decompile, dissemble or
reverse engineer the other Party’s products;         iii. sublicense or transfer
the other Party’s products to any third party;         iv. export the other
Party’s products in contravention of any applicable export regulations;        
v. create, develop, license, acquire, use, or deploy any third-party software or
services to attempt to disable license keys in the other Party’s products; or  
      vi. disclose the results of any benchmark test of the other Party’s
products to any third party without the other Party’s prior written approval.

 

  e. Each Party shall make commercially reasonable efforts to provide
maintenance and support solely for the interoperability of their respective
products in accordance with such Party’s then-current maintenance and support
policy; however, no support for any third party, including but not limited to
customers and partners, shall be provided under this Agreement. Furthermore, to
enable each Party to exercise the rights granted in this Agreement, each Party
shall make available to the other Party access to such Party’s partner website
or portal as is necessary to fulfill this Agreement.         f. The Products of
each Party may contain or be provided with certain third-party proprietary or
open source code. Such third-party or open source code is licensed under the
terms of the applicable license conditions and/or copyright notices that can be
found in the license file, the related documentation or other materials
accompanying the products. Each Party represents that it will comply fully with
the terms and conditions of the applicable third party or open source license
terms. Neither Party shall use open source software in such a way as to subject
any source code thereof of the other party to the provisions of any standards
organization or open source code license which could:

 

  i. require or condition the use or distribution of such source code;        
ii. require the license of any of the other Party’s products and services or any
portion thereof for the purpose of making modifications or derivative works;    
    iii. require the distribution of such source code or any portion thereof
without charge;         iv. require or condition the disclosure, licensing or
distribution of any such source code, any of the other Party’s Products and
services or any portion thereof; or

 

   

 

 

  v. otherwise impose a limitation, restriction or condition on the right of the
other Party or any of its wholly owned subsidiaries to distribute any of the
other Party’s Products and services or any portion thereof.

 

  g. In an abundance of caution, and without limiting the generality of any of
the foregoing, the intention of the Parties is that all licenses and grants
hereunder by SyncHealth to Alliance be exclusive and irrevocable, and all
licenses and grants by Alliance to SyncHealth be non-exclusive and revocable.

 

4. Cooperative Activities.

 

  a. The Parties both agree to allocate and apply sufficient resources and
qualified personnel to meet our obligations hereunder.         b. The Parties
will provide the other Party with its current and available sales brochures and
other sales literature generally made available to its prospects and End Users,
in reasonable quantities.         c. The Parties will provide the other Party
with a profile of its Products and services. Subject to review and approval,
each Party agrees to post the other’s profile on its public web sites (“Party
Profile”). Each Party may use the other’s Marks for the sole purpose of the
Party Profile. Any other reproduction, distribution, or use of the Marks must be
approved in advance by the owning party.         d. Each Party will name a
designated contact for this Agreement.         e. Neither Party is authorized to
make any representation, warranty, endorsement or guarantees concerning the
other Party’s Products, their functionality, interoperability, or performance
characteristics, except to the extent set forth in the marketing literature and
promotional materials delivered by the other Party about the other Party’s
Products.

 

5. Marketing. From time to time, each Party may participate in joint promotional
and marketing activities on mutual agreement and subject to resource
availability. From time to time the Parties may mutually agree to other
cooperative obligations or amendment the current joint marketing activities.

 

  a. SyncHealth may not use or authorize the use of any Marketing Materials in
connection with its activities under this Agreement other than those provided by
Alliance or approved by Alliance in advance in writing. SyncHealth may not
represent to any person orally, in writing, or otherwise that the Alliance
Products have any features, functions, or other qualities other than those
described in the documentation or in Alliance provided or approved Marketing
Materials. Alliance may not use or authorize the use of any Marketing Materials
in connection with its activities under this Agreement other than those provided
by SyncHealth or approved by SyncHealth in advance in writing. Alliance may not
represent to any person orally, in writing, or otherwise that the SyncHealth
Products have any features, functions, or other qualities other than those
described in the documentation or in SyncHealth provided or approved Marketing
Materials.

 

   

 

 

  b. Alliance and SyncHealth will each conduct its business in compliance with
applicable law and its posted privacy policy and will market and sell the other
Party’s Products ethically and in a manner that reflects favorably on each
Party’s reputation. Specifically, but without limitation, Alliance and
SyncHealth will comply with applicable laws as described below in Section 14(h).
Neither Party will make negative comments about the other Party or its products
or services, orally or in writing, to any End User or Opportunity, or in any
public forum.         c. Each Party will use reasonable care to maintain the
confidentiality of its user name, password or other portal access credentials.
Each Party acknowledges that any information on the portal is Confidential
Information of the other Party protected under Section 7.

 

6. Term and Termination.

 

a.

The initial term of this Agreement (the “Initial Term”) begins on the Effective
Date and continues until the second anniversary of the Effective Date. Upon
expiration of the Initial Term, this Agreement will automatically renew for
successive renewal terms of one year each (each a “Renewal Term”) until either
Alliance or SyncHealth gives the other a written notice of nonrenewal at least
ninety (90) days prior to the expiration of the Initial Term, or then-current
Renewal Term, as applicable.         b. Either party may terminate this
Agreement if the other party is in material violation of the Agreement and the
violation is either un-curable or the party in violation fails to cure the
violation within thirty (30) days of the other party’s written notice describing
the violation in reasonable detail.         c. Each Party’s authorization to use
the other Party’s Marks are automatically terminated on termination of this
Agreement and each Party shall immediately stop its marketing efforts.        
d. The following sections survive termination of the Agreement: Section 1
(Definitions) to the extent any defined term is used in another surviving
section, this Section 6 (Term and Termination), Section 7 (Intellectual
Property), Section 8 (Confidential Information), Section 9 (Limit on Liability),
Section 10 (Relationship Between the Parties), Section 11 (Indemnification),
Section 12 (Notices), Section 13 (Governing Law, Disputes), Section 14
(Miscellaneous) and any other section that by its nature is intended to survive
expiration or termination of this Agreement.

 

   

 

 

7. Intellectual Property.

 

  a. The Parties may not use the other Party’s Intellectual Property, Products
and/or Application except as expressly authorized in this Agreement. Except for
the license rights expressly granted in this Agreement, each Party continues to
retain all rights in its Intellectual Property.         b. Each Party may use
the other Party’s Marks in accordance with Section 4(c) and otherwise authorized
from such Party in writing from time to time. Each Party must comply with the
other Party’s trademark usage guidelines published on its partner portal or
otherwise communicated to such Party, as they may be modified from time to time.
Each Party’s use of the other Party’s Marks is subject to the conditions and
requirements of the trademark usage guidelines. SyncHealth’s license to use the
Alliance Marks is non-exclusive, revocable, non-transferable, and
non-sublicensable; conversely, Alliance’s license to use the SyncHealth Marks is
exclusive, irrevocable, transferable and assignable to an Alliance Affiliate.
Each Party’s license to use the other Party’s Marks automatically terminates on
expiration or termination of this Agreement. On termination of the license to
use the other Party’s Marks, such Party will immediately cease using the other
Party’s Marks and will return or destroy all Marketing Materials bearing the
other Party’s Marks as requested by such Party. Each Party agrees that it will
not attempt to register any of the other Party’s Marks, or any name, logo or
other indicia that is confusingly similar to a Mark of such other Party, in any
jurisdiction in the world, will not use the other Party’s Mark in a way that
suggests a general endorsement by the other Party of its activities, and will
not knowingly impair the other Party’s Marks. Except for the rights expressly
granted in this Section or a Party’s trademark usage guidelines, each Party
retains all, right, title and interest in and to its Marks worldwide, including
any non-English language version of the Marks.         c. The term “Partner
Created Technology” means any of the following information or materials and all
related Intellectual Property that are created by a Party, whether created
solely or jointly with a third party, and Partner Pre-Existing Intellectual
Property (as that term is defined below):

 

  i. an extension or utility designed for use with the other Party’s Products;  
      ii. a tool useful in managing data processed by the other Party’s Products
(such as a visualization or workflow tool);         iii. a technology that is
designed to extend or enable the other Party’s Products functionality or the use
of the other Party’s Products; and         iv. Documentation regarding any of
the foregoing.

 

   

 

 

  d. SyncHealth will own the SyncHealth-created Partner Created Technology,
subject to Alliance’s license right stated below. Alliance will own the
Alliance-created Partner Created Technology, subject to SyncHealth’s license
right stated below. “Partner Pre-Existing Intellectual Property” means a Party’s
Intellectual Property that existed prior to the Effective Date of this
Agreement, or that was created by such Party during the Term of this Agreement,
either alone, or jointly with the other Party or the End User or any other
person. For avoidance of doubt, neither is authorized to modify the Products of
the other Party or create derivative works of such Products.         e.
SyncHealth hereby licenses Alliance to make, have made, use, sell, offer for
sale, import, copy, reproduce, display, perform, modify, create derivative
works, distribute, commercialize, exploit, and otherwise dispose of in any
manner now known or in the future discovered, the SyncHealth-created Partner
Created Technology on an exclusive, perpetual, royalty free, fully-paid,
irrevocable, worldwide, unconditional, fully transferable basis. Alliance hereby
licenses SyncHealth to make, have made, use, sell, offer for sale, import, copy,
reproduce, display, perform, modify, create derivative works, distribute,
commercialize, exploit, and otherwise dispose of in any manner now known or in
the future discovered, the Alliance-created Partner Created Technology on a
non-exclusive, perpetual, royalty free, fully-paid, revocable, worldwide,
unconditional, non-transferable basis.         f. Each Party’s use of the other
Party’s Products, Marketing Materials, Marks and Confidential Information are
subject to terms and conditions stated in other sections of this Agreement. Any
information or materials provided by a Party to the other Party in connection
with the Agreement that are not Products, Marketing Materials, Marks, or
Confidential Information are “Other Party Materials” subject to the terms and
conditions stated in this Subsection. Each Party is licensed to use Other Party
Materials on a non-exclusive, revocable basis, solely for use in marketing and
selling the Alliance and SyncHealth Products. Each Party may transfer and
sublicense the Other Party Materials to its authorized subcontractors as
described in Section 14(a), and if the Other Party Materials have been released
on a “generally available” basis by such Party. Neither Party may otherwise
transfer or sublicense the Other Party Materials.

 

8. Confidential Information; Personally Identifiable Information.

 

  a. Information disclosed by a party or its Affiliates (the “Discloser”) to the
other party or its Affiliates (the “Recipient”) regarding the Discloser’s
assets, liabilities, financial results, financing plans, business strategies,
pricing, discounts, product development plans, marketing strategies, operations,
source code, technology, know-how, trade secrets, customers, channels,
contractors, suppliers, employees and other personnel, and all other information
that the Recipient should reasonably understand to be confidential, due to the
nature of the information or the circumstances of its disclosure, is
“Confidential Information” of discloser, regardless of the form or manner in
which it is disclosed, and regardless of whether the information is marked or
designated as confidential. Each Party acknowledges that the terms of this
Agreement are Confidential Information of the other Party.

 

   

 

 

  b. Information that would otherwise be Confidential Information under this
Agreement shall not be Confidential Information if the information: (i) becomes
publicly known through no fault of Recipient, (ii) was rightfully known by
Recipient, or in Recipient’s possession, before Discloser’s disclosure as
evidenced by Recipient’s written business records; (iii) is disclosed to
Recipient by a third party who, to Recipient’s knowledge, acquired the
information without violation of law or contract, and who does not have an
obligation of confidentiality to Discloser with respect to the information; or
(iv) is independently developed by Recipient without any use of, access to, or
reference to the Confidential Information of Discloser as evidenced by
Recipient’s written business records.         c. The Recipient shall not
disclose Discloser’s Confidential Information except to Recipient’s employees,
and to third parties who need to know the information to represent or advise the
Recipient with respect to the subject matter of this Agreement, provided that
all employees and third party recipients must be bound by written
confidentiality obligations covering the Confidential Information that are at
least as stringent as those stated in this Agreement. Recipient shall not use
the Confidential Information except in connection with the Business Purpose, the
performance of its obligations or exercise of its rights under this Agreement.
However, Recipient shall not be in violation of this Section if it discloses or
uses Discloser’s Confidential Information to comply with a legal requirement,
such as a subpoena or preservation order, or to bring or defend a claim in a
adjudicatory proceeding, provided that Recipient has limited its disclosure to
only that Confidential Information reasonably necessary in light of
circumstances, and has given Discloser reasonable advance notice of the
disclosure or use (unless such notice is prohibited by law). Recipient will use
reasonable care to protect the Confidential Information from unauthorized use
and disclosure. Recipient shall return or destroy the Confidential Information
upon expiration or termination of this Agreement or earlier on Discloser’s
request, provided that Recipient may retain the Confidential Information as part
of its reasonable and customary business records. On Discloser’s request,
Recipient shall certify its compliance with the preceding sentence. Recipient is
responsible for a breach of this Section by its agents or representatives.

 

   

 

 

  d. Notwithstanding anything to the contrary contained in this Agreement, with
respect to any personally identifiable information that can be used to identify,
contact, locate, or be traced back to the specific person to whom such
information pertains (“PII”) delivered or made available to a Party under or
pursuant to this Agreement, each Party agrees that:

 

  i. Neither Party shall use, process, copy, display, publish, store or transfer
the PII except for the sole purpose of carrying out its obligations as expressly
set forth in this Agreement;         ii. Each Party shall comply with the other
Party’s data privacy and security requirements and shall prevent the
unauthorized use, dissemination, or publication of PII by: (i) maintaining an
effective information security program; (ii) keeping PII strictly confidential;
and (iii) taking appropriate administrative, technical and physical measures to
secure and protect the PII against unauthorized, unlawful or accidental access,
disclosure, transfer, destruction, loss or alteration. Without limiting the
generality of the foregoing, technical and organizational measures to protect
PII shall include those measures required by all applicable local, state,
national, and international laws, as well as any additional safeguards required
by a Party. In addition, each Party is required to encrypt PII while in storage
or transit and shall follow all industry best practices to monitor unauthorized
access of PII.         iii. Each Party must have or implement appropriate
policies and procedures to ensure that: (i) unauthorized persons will not have
access to the PII; (ii) access to the PII shall be limited to a need-to-know
basis; and (iii) any employees (and subcontractors, if permitted pursuant to (d)
below) authorized by Each Party to access the PII will be informed of its highly
confidential nature, the limitations and procedures that apply to access and use
of the PII, and that they must maintain the confidentiality and security of the
PII.         iv. Neither Party shall disclose or make the PII available to
subcontractors without entering into an agreement in writing with the
subcontractor whereby the subcontractor agrees to comply with and treat the PII
in accordance with this Agreement. Each Party shall be responsible for all
breaches by its employees, representatives, agents, and subcontractors.        
v. Each Party shall promptly notify the other Party in writing if such Party
becomes aware of any unauthorized access to the PII, or if such Party becomes
the subject of any governmental, regulatory, or other enforcement or private
proceeding relating to its data handling practices.         vi. When collecting,
using, storing, transferring and otherwise processing the PII, each Party shall
adhere to all applicable export and data privacy laws, regulations and rules,
domestically and internationally, including any additional requirements
communicated by a Party, as well as each Party’s applicable privacy policies. In
the case of any legal or regulatory obligation to disclose the PII, each Party
shall: (i) promptly notify and cooperate with the other Party; (ii) limit any
disclosure to the minimum required by law; and (iii) to the extent possible,
request that such information be kept confidential.

 

   

 

 

  vii. Each Party shall provide the other Party with information regarding its
privacy and data protection practices and allow the other Party reasonable
access to audit and inspect such Party’s records, processes and facilities to
determine if such Party is in compliance with its obligations hereunder, as well
as each Party’s data privacy and security requirements, including, without
limitation, compliance with applicable data privacy laws, regulations and rules.
        viii. Each Party shall, on termination of this Agreement or at any other
time requested by the other Party, promptly and in a secure manner return to the
other Party all PII and any copies thereof, or at such other Party’s written
direction, destroy the PII and copies thereof (and certify that this has been
done). Notwithstanding the foregoing, if applicable legislation or legal action
prevents a Party from returning or destroying the PII, such Party shall, at no
additional expense to the other Party, keep the PII and copies thereof secure
and confidential and no longer process or otherwise use such PII, until such
time that such legislation or legal action no longer prevents such Party from
returning or destroying the PII in the manner required in the first sentence
above.         ix. Each Party shall promptly notify the other Party of any
access requests made to such Party directly by individuals whose PII may have
been delivered or made available to such Party pursuant to this Agreement (“data
subjects”), and shall, prior to responding to such request, provide the other
Party with copies of any such PII that such Party is processing on behalf of the
other Party within such reasonable time limits as may be specified by the other
Party. Such other Party shall have the option, at its discretion, to respond
directly to the data subjects in lieu of such Party.         x. Each Party must
have a disaster recovery plan in effect at all times and provide copies of their
disaster recovery plans to the other Party. Any modifications to the plans must
be communicated to the other Party in writing in advance and approved by the
other Party prior to implementation. Disaster recovery plans should include
disaster avoidance and contingency plans in the event telephone service,
Internet services, computer systems, facility power, or physical access
(including employee turnover scenarios) to a Party’s facility is affected.      
  xi. The restrictions on the use and disclosure of PII set forth herein shall
survive the expiration or termination of the Agreement. Each Party’s obligations
hereunder may not be assigned to another party without the prior written consent
of the other Party, which consent may be withheld in such other Party’s sole
discretion.

 

   

 

 

9. Limit on Liability. In no event shall any Party be liable for any
consequential, exemplary, special, indirect, incidental or punitive damages,
including any lost profit or lost savings even if such Party has been advised of
or should be aware of the damages.     10. Relationship Between the Parties.
SyncHealth does not have any right of exclusivity with respect to the Alliance
Products or any other aspect of its relationship with Alliance. Alliance may
market and sell any of its products or services, including the Alliance Products
as defined in this Agreement, either directly or via channels. SyncHealth may
market and sell the Alliance Products only to persons who intend to use the
Alliance Products for their internal business purposes. The Parties are
independent contractors. Neither Party is the agent of the other Party; and
neither Party has the authority to bind the other Party to any agreement.    
11. Indemnification. Each Party will indemnify and hold harmless the other Party
and its employees, agents, Affiliates and suppliers from any damages,
liabilities, judgments, fines, penalties, costs, and expenses (including
reasonable attorney fees) that arise from or relate to (i) such Party’s breach
or default of this Agreement; (ii) such Party’s gross negligence or willful
misconduct; and (iii) any claim brought by or through the End User of the other
Party’s Products, customer or other third party claim alleging such Party’s
breach of this Agreement, violation of law, negligence, or misconduct. At an
indemnified Party’s request, the other Party will defend an indemnified claim at
such other Party’s expense.     12. Notices. The parties address for notice
purposes appear in the Agreement preamble. Notices under this Agreement must be
given by electronic mail with a copy transmitted via first class United States
mail on the date of the electronic mail notice. Notices are deemed given,
received and effective as of the time transmitted by electronic mail, or if that
time does not fall within a business day, as of the beginning of the first
business day following the time transmitted. Notices must be given in the
English language. A party may change its address for notice by giving notice in
the manner stated in this Section.     13. Governing Law, Disputes. This
Agreement shall be governed by and interpreted under the laws of the State of
Florida and the United States of America, as applicable, without giving effect
to any conflicts of law principles that would require the application of the law
of a different jurisdiction. The parties agree that any lawsuit or other action
related to this Agreement shall be brought in Hillsborough County, Florida to
the exclusion of any other court or tribunal, and that neither of them shall
dispute the personal jurisdiction of such court. To the extent permitted by law,
each party waives the right to a trial by jury in respect of any litigation
arising out of or related to this Agreement or the parties’ activities in
connection with this Agreement.

 

   

 

 

14. Miscellaneous.

 

  a. Neither party may assign this Agreement without the prior consent of the
other except that Alliance may assign the Agreement as part of a transaction by
which it transfers all or substantially all of its assets without SyncHealth’s
consent and each Party may sublicense its rights hereunder to its channel
partners, distributors, Affiliates and subcontractors on an as-needed basis.    
    b. The parties contemplate they shall cooperate in good faith to issue
appropriate publicity consistent with program criteria.         c. Unless
otherwise expressly stated, neither Party makes any representation or warranty
regarding the Products and each of them are provided AS IS WITH ALL FAULTS.
Neither Party warrants that the other Party’s use of the Products of a Party
will be error free, uninterrupted or completely secure. Each Party disclaims any
implied or statutory warranties, such as a warranty of merchantability, fitness
for a particular purpose, lack of malware, and non-infringement, and disclaims
any warranty that may arise from a course of dealing.         d. Except as
otherwise provided above, this Agreement may be modified only by a written
document that expressly refers to this Agreement by name and date and is signed
by the parties. No right or remedy arising in connection with this Agreement
shall be waived by a course of dealing between the parties, or a party’s delay
in exercising the right or remedy. A party may waive a right or remedy only by
signing a written document that expressly identifies the right or remedy waived.
Unless expressly stated in the waiver, a waiver of any right or remedy on one
occasion will not be deemed a waiver of that right or remedy on any other
occasion, or a waiver of any other right or remedy. The pre-printed terms of the
parties’ business forms shall be of no force or effect whatsoever.         e. In
the event one or more of the terms of this Agreement are adjudicated invalid,
illegal, or unenforceable, the adjudicating body may either interpret this
Agreement as if such terms had not been included or may reform such terms to the
limited extent necessary to make them valid, legal or enforceable, consistent
with the economic and legal incentives underlying the Agreement.         f.
Unless and to the extent specifically stated otherwise in some other section of
this Agreement, there are no third-party beneficiaries to this Agreement.
Neither party’s customers, End Users, suppliers or other person shall have the
right to enforce this Agreement.         g. This Agreement may be signed in
multiple counterparts, which taken together shall be read as one Agreement. A
signed agreement transmitted by facsimile, email attachment, or other electronic
means shall be considered an original. The parties agree that electronic or
digital signatures shall be given the same effect as a manual signature. The
pre-printed terms on a Party’s purchase orders or other business forms shall
have no effect whatsoever.         h. The Parties agree to comply with all
applicable laws, including, without limitation, Health Insurance Portability and
Accountability Act of 1996 (HIPAA), the Model State Pharmacy Act and Model Rules
of the National Association of Boards of Pharmacy (Model Act), the Prescription
Drug Marketing Act of 1987 (PDMA), the FDA’s Guidelines for State Licensing of
Wholesale Prescription Drug Distributors (21 CFR 205), the U.S. Foreign Corrupt
Practices Act of 1977 and any other applicable laws or regulations. The Parties
agree to comply fully with all relevant export laws and regulations, including
but not limited to the U.S. Export Administration Regulations and regulations
promulgated by the U.S. Department of the Treasury’s Office of Foreign Assets
Control (“OFAC”), as amended from time to time (collectively, the “Export
Control Laws”). The Parties agree not to export or re-export their respective
products to any parties located in Iran, Cuba, North Korea, Syria, Sudan or any
other countries prohibited under U.S. embargoes or sanctions programs maintained
by the OFAC or otherwise prohibited under the Export Control Laws. SyncHealth
must obtain the written permission of Alliance for any activities or licensing
related to the Alliance Products for the countries outside the United States.
This Agreement is the complete and exclusive agreement between the parties
regarding its subject matter and supersedes and replaces in its entirety any
prior or contemporaneous agreement or understanding regarding the subject matter
of this Agreement, written or oral.

 

Remainder of page blank; signature page follows.

 

   

 

 

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date
first referenced above.

 

TRXADE: SYNCHEALTH:     ALLIANCE PHARMA SOLUTIONS, LLC SYNCHEALTH MSO, LLC

 

By:     By: PanOptic Health, LLC Surendra Ajjarapu   Its: Manager Its: Chief
Executive Officer                   By:         Meriam Ibrahim       Its:
Manager